For a special limited time:

         Save 30%!

 Get all 3:


  for one low price.

                Learn more

Ringing in 2014 with 20% portfolio gain

publication date: Jan 13, 2014
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Ringing in the New Year up 20.8%


The start to 2014 has been outstanding for our flagship Cell Signaling and Cancer Stem Cells portfolio.

cancer stem cells portfolio

(access portfolio as premium member)
The 20.8 % jump start of 2014

Portfolio gain 310.8%

With 4 of the 9 stocks in the portfolio notching double digit gains, it’s already a happy new year for subscribers.  The portfolio is up 20.8% in the 7 trading days of 2014 with these 4 stocks popping 18%, 24%, 31% and 94%.  It’s very gratifying to see our last transaction pay off in relatively short order with the “stealth good news” transaction we delivered to you nearly doubling.  

We are also very excited to see some momentum in the science themes of the newsletter with substantial supporting marketplace developments in the area of cancer stem cells as well as RNAi.

For a refresher on these Day 1 themes as key biotech investments it’s good to review This Changes Everything.


Sorry this page is available to premium members only.
If you're not a premium member why not join today?

If you are already a premium member, please login.

If your trial membership to currinBIOTECH has expired join today.

If you are a CurrinTechnology or Rick's Research member you can upgrade to currinBIOTECH at a specially reduced rate to become a Power Package member.

Click here to start your Power Package membership.


If you believe you should be able to view this area then please contact us and we will try to rectify this issue as soon as possible.

To gain access to the premium members only content click here to join.

You will be given immediate access to premium content on the site.

Benefits of Premium Membership include:

  • access to all site content and  newsletter reports
  • acess to all portfolio information and transaction alerts
  • access to all Special Feature, Industry Focus, and Companies in Focus reports
  • email alerts of transactions and any portfolio changes